BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.02B |
| 2 |
Apple
AAPL
|
+$2.03B |
| 3 |
Amazon
AMZN
|
+$1.93B |
| 4 |
Microsoft
MSFT
|
+$1.89B |
| 5 |
Uber
UBER
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$5.15B |
| 2 |
VMW
VMware, Inc
VMW
|
+$2.9B |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$2.56B |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.72B |
| 5 |
Danaher
DHR
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 12.77% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
Lantern Pharma
LTRN
$35.9M
| $85.4K | ﹤0.01% |
19,962
-186
| -0.9% | -$656 |
|
4627
Phunware
PHUN
$41.7M
| $85.4K | ﹤0.01% |
20,835
| – | – |
|
4628
Broadway Financial
BYFC
$104M
| $85.2K | ﹤0.01% |
12,558
+949
| +8% | +$6.45K |
|
4629
US Gold Corp
USAU
$251M
| $85.2K | ﹤0.01% |
20,036
-236
| -1% | -$810 |
|
|
KUST
4630
Kustom Entertainment Inc
KUST
$683K
| $84.4K | ﹤0.01% |
1
| – | – |
|
4631
Natural Alternatives International
NAII
$14.6M
| $84.4K | ﹤0.01% |
12,921
-140
| -1% | -$881 |
|
|
BCEL
4632
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $84.2K | ﹤0.01% |
637,974
-547,684
| -46% | -$129K |
|
|
CLYM
4633
Climb Bio
CLYM
$778M
| $84.1K | ﹤0.01% |
31,145
-166
| -0.5% | -$432 |
|
4634
BK Technologies
BKTI
$281M
| $84K | ﹤0.01% |
6,868
-82
| -1% | -$1.06K |
|
4635
CareCloud
CCLD
$102M
| $83.7K | ﹤0.01% |
55,045
-292
| -0.5% | -$317 |
|
4636
BlackRock Science and Technology Term Trust
BSTZ
$2.08B
| $83.5K | ﹤0.01% |
5,000
| – | – |
|
4637
Rhinebeck Bancorp
RBKB
$195M
| $83.2K | ﹤0.01% |
10,334
-124
| -1% | -$823 |
|
4638
United-Guardian
UG
$33.4M
| $83.1K | ﹤0.01% |
11,545
-114
| -1% | -$832 |
|
4639
Where Food Comes From
WFCF
$62.5M
| $82.9K | ﹤0.01% |
6,119
-68
| -1% | -$918 |
|
|
OMCC
4640
DELISTED
Old Market Capital Corp
OMCC
| $82.8K | ﹤0.01% |
12,001
-407
| -3% | -$2.33K |
|
|
BLTE
4641
Belite Bio
BLTE
$6.7B
| $82.6K | ﹤0.01% |
+1,805
| New | +$69.4K |
|
4642
Ebang International Holdings
EBON
$13M
| $82.4K | ﹤0.01% |
5,387
| – | – |
|
4643
MiNK Therapeutics
INKT
$54.6M
| $81.8K | ﹤0.01% |
7,646
-404
| -5% | -$4.22K |
|
4644
Theriva Biologics
TOVX
$10.6M
| $81.7K | ﹤0.01% |
7,602
-5
| -0.1% | -$62 |
|
4645
Corvex Inc
MOVE
$324M
| $81.6K | ﹤0.01% |
945
+70
| +8% | +$6.59K |
|
4646
Invesco S&P 500 GARP ETF
SPGP
$2.32B
| $81.2K | ﹤0.01% |
828
+669
| +421% | +$61.8K |
|
|
SCHV
4647
Schwab US Large-Cap Value ETF
SCHV
$16.1B
| $81K | ﹤0.01% |
3,468
+3,051
| +732% | +$66.7K |
|
4648
Franklin Wireless
FKWL
$27.9M
| $80.8K | ﹤0.01% |
23,833
+2,587
| +12% | +$7.73K |
|
4649
ImmuCell
ICCC
$99.2M
| $79K | ﹤0.01% |
15,512
-918
| -6% | -$4.48K |
|
|
TRVN
4650
DELISTED
Trevena, Inc.
TRVN
| $77.9K | ﹤0.01% |
4,317
-164
| -4% | -$2.45K |
|
Similar funds
BlackRock's Q4 2023 Portfolio in Review
As of Q4 2023, BlackRock held 5,578 positions worth $3.92T, up 13% from $3.48T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q4 2023 filing shows 129 new, 3,072 increased, 1,515 reduced and 203 closed positions. Its largest new stake was NCR Atleos: 8,735,537 shares worth $212M. The largest sale was Activision Blizzard, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2023 buy was NCR Atleos: 8,735,537 shares worth $212M.
- BlackRock added most to Broadcom in Q4 2023, an estimated $3.02B increase.
- BlackRock's biggest Q4 2023 reduction was Danaher, cutting an estimated $1.02B.
- BlackRock fully exited Activision Blizzard in Q4 2023, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 22% of its $3.92T portfolio in Q4 2023.
- BlackRock opened 129 new positions and closed 203 in Q4 2023.
- BlackRock's portfolio value rose 13% quarter-over-quarter to $3.92T.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.